CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

RealTime Software Solutions Acquires Complion

RealTime Software Solutions Acquires...

What role does artificial intelligence play in the employment process?

What role does artificial...

Why AI is Used for Quality Management in Life Science

Why AI is Used for Quality Management...

Application of AI in Genetics

Application of AI in Genetics

How Artificial Intelligence Impacts Biotechnology

How Artificial Intelligence Impacts...

Akanta's Contextual Intelligence 360 to Enhance Customer Experience

Akanta's Contextual Intelligence 360...

MMIT/Evaluate to Boost Pharma Analytics After Acquisition of Panalgo

MMIT/Evaluate to Boost Pharma...

Syneos Health's Acquisition of RxDataScience to Help Boost Product Development

Syneos Health's Acquisition of...

RealTime Software Solutions Acquires Complion

RealTime Software Solutions Acquires...

What role does artificial intelligence play in the employment process?

What role does artificial...

Why AI is Used for Quality Management in Life Science

Why AI is Used for Quality Management...

Application of AI in Genetics

Application of AI in Genetics

How Artificial Intelligence Impacts Biotechnology

How Artificial Intelligence Impacts...

Akanta's Contextual Intelligence 360 to Enhance Customer Experience

Akanta's Contextual Intelligence 360...

MMIT/Evaluate to Boost Pharma Analytics After Acquisition of Panalgo

MMIT/Evaluate to Boost Pharma...

Syneos Health's Acquisition of RxDataScience to Help Boost Product Development

Syneos Health's Acquisition of...

How Biopharma Companies Improve Drug Research and Development Using AI

Life Sciences Review | Wednesday, September 15, 2021
Tweet

The COVID-19 pandemic has heightened interest in applying artificial intelligence (AI) throughout the health sciences industry, from research and development to manufacturing, supply chain, and commercial operations.


FREMONT, CA: In the future of health, AI will speed up the development of new medicines and vaccinations. AI can assist find and validate genetic targets for drug research, create novel molecules and accelerate drug development.


The most effective use of AI is going to be a strategic deployment across the entire organization. With cross-functional collaboration, a governance framework that prioritizes business goals, and a uniform approach to cyber and compliance challenges, biopharma businesses will be able to maximize their AI investments.


Research and development


Drug discovery is a complex, manual, and capital-intensive process that can be automated or enhanced by AI. Biopharma companies are already testing AI to speed up drug discovery. Firms might utilize AI models to identify and assess objectives in the next five years to strengthen predictive capabilities. This might drastically speed up the drug discovery process.


There is a rising need for solutions that may transform and accelerate target identification and validation. AI imaging can identify changes in cell morphology that a microscope cannot perceive. The use of AI to analyze knowledge graphs could help grasp intricate interactions between proteins and chemicals.Using AI to interpret phenotypic changes in cells via imaging could help validate targets through functional genomics investigations (noncoding changes that affect expression).  


To avoid costly late-stage drug development failures, acquiring genetic evidence for target identification will become a strategic goal.


Some startups are already pioneering generative modelling for small molecule creation and protein engineering collaboration with established biopharma businesses through cooperation with established biopharma businesses. Simultaneously, biopharma firms are developing their tools to assist medicinal chemists in their work. In the next five years, generative modeling may become a vital tool in computational chemistry, allowing companies to investigate new areas and expand their drug candidate pool.


Creating trial artefacts today entails manually entering data into many systems. This causes inconsistencies, errors, and rework, slowing trial execution. AI-powered digital data flow solutions could normalize trial data from diverse source systems and documents for downstream systems. These data elements can then be used to auto-generate reports and analysis and trial artefact material. Some businesses are already testing AI to handle clinical trial data better.


Over the coming decade, clinical trial designers will increasingly target patient populations to establish efficacy, minimizing development time and failures. Data normalization and integration (genotypic, imaging, clinical records, and epidemiological) will be increasingly used by AI to improve patient stratification and trial success. After the treatment is approved/commercialized, AI-enabled companion diagnostics techniques (e.g., those used to screen for biomarkers) could better understand the response profile.


See Also: BioTech Startups in APAC


Weekly Brief

loading
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

The Role of AI in Accurate Medical Writing

Patrik Renblad to Join Cantargia as Chief Financial Officer

Overview of the Life Sciences BPO Market

Dr. Zamaneh Mikhak Joins TFF Pharmaceutical as the New Chief Medical Officer

The Significance of AI in Medical Writing

The Importance of Technology in Multinational Clinical Research

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/how-biopharma-companies-improve-drug-research-and-development-using-ai-nwid-561.html